Government ❯ Health ❯ Healthcare

Regulations

Product Safety Cannabis FDA Cosmetic Safety Food Safety Pharmaceuticals National Pharmaceutical Pricing Authority Chronic Conditions Hospital Compliance Drug Approval Processes

Brazil's Anvisa Orders Recall of Five Impala Gel Nail Polish Lines

The order follows a voluntary recall by manufacturer Laboratório Avamiller over the banned ingredient TPO.

ANMAT Bans Unregistered Hair Treatments and Dental Suture Nationwide Over Safety Risks

ANMAT Pulls Dozens of Unregistered Cosmetics, Hair Products and Perfumes From Argentina’s Market

ANMAT Expands Nationwide Bans to Unregistered Hair Lines, Mentisan Ointment and Antifungal Spray

Anvisa Unveils Draft to Authorize Domestic Medicinal Cannabis Cultivation Ahead of March 31 Deadline

Anvisa Bans 30 Landerlan Anabolic Products Over Lack of Registration

ANMAT Widens Nationwide Bans to Unregistered Soaps and High‑Risk Medical Devices

Sindh Caps Prices for Dengue, Malaria and CBC Tests Through December 31

FDA Escalates Crackdown on Drug Ads, Moves to Close ‘Adequate Provision’ Loophole

FDA to Publicly Release All Future Drug Rejection Letters, Posts 89 Recent CRLs

India Fixes Ceiling Prices for 37 Essential and Four Emergency Medicines

ANMAT Extends Nationwide Bans to Hair-Care Lines and Influencer-Promoted Dental Products

Telangana, Andhra Pradesh Intensify Inspections of Fertility Clinics After Surrogacy Fraud

ANMAT Bans Olive Oils, Sugar, Cannabis Ointment and Medical Devices Nationwide

FDA and A.P. Deauville Recall Over 67,000 Cases of Power Stick Roll-On Deodorant

ANMAT Prohibits Dutaflox Duo Lot B461 and Illicit Health and Beauty Products

FDA and A. P. Deauville Recall Over 67,000 Power Stick Roll-On Deodorants

Galicia Opens Public Consultation on Home Delivery Decree for Dependent Patients

Audit Flags Potential Fraud and Excessive Spending in Newfoundland’s Travel Nurse Contracts